Current Medical Research and Opinion

Preferences of healthy men for two different endocrine treatment options offered for locally advanced prostate cancer
pp. 1329-1336(8)
Authors: Jenkins, V.; Fallowfield, L.; Edginton, T.; Payne, H.; Hamilton, E.

Alcoholic hepatitis: from pathogenesis to treatment
pp. 1337-1346(10)
Authors: Sougioultzis, S.; Dalakas, E.; Hayes, P.C.; Plevris, J.N.

Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents
pp. 1347-1354(8)
Authors: Mark, Tami L.; McKenzie, R. Scott; Fastenau, John; Piech, Catherine Tak

Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures
pp. 1355-1362(8)
Authors: Gallacher, S.J.; McQuillian, C.; Harkness, M.; Finlay, F.; Gallagher, A.P.; Dixon, T.

Carbamazepine extended-release capsules vs. oxcarbazepine: computer simulations of the effect of missed doses on drug plasma concentrations
pp. 1363-1368(6)
Authors: Ahmad, Alaa; Garnett, William R.

Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression
pp. 1369-1376(8)
Authors: Lee, Min-Soo; Ham, Byung Joo; Kee, Baik Seok; Kim, Jung-Bum; Yeon, Byeong Kil; Oh, Kang-Seob; Oh, Byoung Hoon; Lee, Chul; Jung, Han Yong; Chee, Ik-Seung; Choe, Byeong Moo; Paik, In Ho

Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research
pp. 1377-1388(12)
Authors: Rosenwasser, Lanny J.; O'Brien, Terrence; Weyne, Jonathan

Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study
pp. 1389-1400(12)
Authors: Van Ganse, Eric; Laforest, Laurent; Alemao, Evo; Davies, Glenn; Gutkin, Stephen; Yin, Don

Comment on Post-marketing surveillance: a UK/European perspective
pp. 1401-1402(2)
Author: Dornhorst, Anne

Safety and efficacy of colesevelam hydrochloride in combination with fenofibrate for the treatment of mixed hyperlipidemia
pp. 1403-1412(10)
Authors: McKenney, James; Jones, Michael; Abby, Stacey

Overactive bladder in women: symptom impact and treatment expectations
pp. 1413-1422(10)
Authors: MacDiarmid, Scott; Rosenberg, Matt

Early onset effects of galantamine treatment on attention in patients with Alzheimer's disease
pp. 1423-1430(8)
Authors: Vellas, Bruno; Cunha, Luís; Gertz, Hermann-Josef; De Deyn, Peter Paul; Wesnes, Keith; Hammond, Gerry; Schwalen, Susanne; on Behalf of the GAL-INT-28 Study Group,

Errata
pp. 1431-1432(2)

Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31793 patients
pp. 1433-1440(8)
Authors: Strutz, F.; Bramlage, P.; Paar, W.D.

Safety assessment of raloxifene over eight years in a clinical trial setting
pp. 1441-1452(12)
Authors: Martino, Silvana; Disch, Damon; Dowsett, Sherie A.; Keech, Cheryl A.; Mershon, John L.

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis
pp. 1453-1460(8)
Authors: Cramer, Joyce A.; Amonkar, Mayur M.; Hebborn, Ansgar; Altman, Roy

Differences between statins on clinical endpoints: a population-based cohort study
pp. 1461-1468(8)
Authors: Dieleman, Jeanne P.; van Wyk, Jacobus T.; van Wijk, Marc A.M.; van Herpen, Gé; Straus, Sabine M.J.M.; Dunselman, Hans; Sturkenboom, Miriam C.J.M.

Effects of rosuvastatin on endothelial function in patients with familial combined hyperlipidaemia (FCH)
pp. 1469-1476(8)
Authors: ter Avest, Ewoud; Abbink, Evertine J.; Holewijn, Suzanne; de Graaf, Jacqueline; Tack, Cees J.; Stalenhoef, Anton F.H.

Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
pp. 1477-1484(8)
Authors: Davis, Ruth E.; Morrissey, Malcolm; Peters, John R.; Wittrup-Jensen, Kim; Kennedy-Martin, Tessa; Currie, Craig J.

Low-dose cyclobenzaprine versus combination therapy with ibuprofen for acute neck or back pain with muscle spasm: a randomized trial
pp. 1485-1494(10)
Authors: Childers, Martin K.; Borenstein, David; Brown, Richard L.; Gershon, Steven; Hale, Martin E.; Petri, Michelle; Wan, George J.; Laudadio, Charles; Harrison, Diane D.

Suppression of the histamine-induced wheal and flare response by fexofenadine HCl 60 mg twice daily, loratadine 10 mg once daily and placebo in healthy Japanese volunteers
pp. 1495-1504(10)
Authors: Boyle, Julia; Ridout, Fran; Meadows, Robert; Johnsen, Sigurd; Hindmarch, Ian

Current Medical Research and Opinion Notes for Contributors
pp. i-vi(6)